1.10

1.79% -0.02

Cocrystal Pharma Inc (COCP)

Overview News Price History Financials Discussions Forecast Stock Split

Cocrystal Pharma Inc stock is traded at $1.10, with a volume of 23,124. It is down -1.79% in the last 24 hours and up +15.79% over the past month. Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Previous Close:

$1.12

Open:

$1.14

24h Volume:

23,124

Relative Volume:

0.29

Market Cap:

$21.14M

Revenue:

Net Income/Loss:

$-8.83M

P/E Ratio:

-1.5044

EPS:

-0.7312

Net Cash Flow:

$-8.01M

1W Performance:

+1.85%

1M Performance:

+15.79%

6M Performance:

+18.28%

1Y Performance:

-35.10%

1-Day Range:

$1.09

$1.1473

1-Week Range:

$1.0601

$1.15

52-Week Range:

$0.76

$2.67

Cocrystal Pharma Inc Stock (COCP) Company Profile

Name

Cocrystal Pharma Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

(786) 459-1831

Address

19805 N. CREEK PARKWAY, BOTHELL, WA

Employee

Twitter

@cocrystalpharma

Next Earnings Date

2026-08-13

Latest SEC Filings

COCP's Discussions on Twitter

Compare COCP vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COCP Cocrystal Pharma Inc	1.0974	21.57M	0	-8.83M	-8.01M	-0.7312
VRTX Vertex Pharmaceuticals Inc	515.89	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.79	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	992.63	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.22	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.16	39.31B	5.76B	514.49M	1.10B	4.4813

Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-20	Initiated	H.C. Wainwright	Buy

Cocrystal Pharma Inc Stock (COCP) Latest News

11:45 AM

Cocrystal Pharma Appoints Antiviral Drug Expert Carol Brosgart to Board - citybiz

11:45 AM

11:28 AM

Cocrystal Pharma appoints Carol Brosgart to board of directors By Investing.com - Investing.com Canada

11:28 AM

11:22 AM

Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors - The Manila Times

11:22 AM

11:20 AM

Cocrystal Pharma Appoints Carol Brosgart, M.D. to Board of Directors - Quiver Quantitative

11:20 AM

11:17 AM

A Gilead veteran joins Cocrystal’s board to guide antiviral drug development - Stock Titan

11:17 AM

Aug 13, 2026

Cocrystal Pharma Q2 Results: EPS Loss Widens to $(0.23), Misses Estimate - scanx.trade

Aug 13, 2026

Cocrystal Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2026

Cocrystal Pharma (COCP) flags going-concern risk amid Q2 2026 loss and $5M raise - Stock Titan

Aug 13, 2026

Aug 10, 2026

Cocrystal Pharma’s single oral drug for multiple viruses - drugdiscoverytrends.com

Aug 10, 2026

Cocrystal Pharma Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView

Aug 10, 2026

Aug 09, 2026